Merger Notification - Announcement according to § 10 Cartel Act
LEO Pharma A/S; Teile des Geschäftsbereichs der Bayer Gruppe
BWB/Z-4051
On 02.08.2018 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
LEO Pharma А/Ѕ (Ballerup/Denmark) intends to acquire certain parts of the Rx dermatology business and certain skin cosmetic brands from the Bayer group. The intended concentration concerns dermatology products. Affected business areas are pharmaceuticals.
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 30.08.2018.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 31.08.2018 .